Insider filing · RGNX
Gregory Austin Ciongoli
Director
profile →
REGENXBIO Inc.
RGNX · Healthcare · 6 filings in 24 months
ticker →
Gregory Austin Ciongoli bought $949K of REGENXBIO (RGNX)
Executed Aug 26, disclosed Aug 27, 1 day later.
Value, as filed
$949K
102,603 sh across 2 lots
Executed
Aug 26
the trade date, as filed
Disclosed
Aug 27
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
not yet measured
Not yet measured: the 21-session window has not closed, or the prices around it are not on record.
The filer
GCGregory Austin Ciongoli (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in REGENXBIO Inc. (RGNX). The largest single filing was $949K of RGNX (102,603 sh across 2 lots, as filed), executed Aug 26. The median gap between execution and disclosure was 1 day.
The name
RGNXHealthcare · REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→